Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Farrant

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neurology|September 4, 2009
Prospective validation of the ICH Score for 12-month functional outcomeJ Claude Hemphill, Mary Farrant, Terry A Neill
Neurocritical Care|December 27, 2005
Brain tissue oxygen monitoring in intracerebral hemorrhageJ Claude Hemphill, Diane Morabito, Mary Farrant, et al.
Neurocritical Care|September 22, 2005
External validation of the ICH scoreJennifer L Clarke, S Claiborne Johnston, Mary Farrant, et al.
Journal of the American Heart Association|March 8, 2021
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT TrialHooman Kamel, Mary Farrant, J Donald Easton, et al.
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
JAMA Neurology|August 20, 2019
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) TrialsYuesong Pan, Jordan J Elm, Hao Li, et al.
Circulation|June 27, 2019
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic StrokeS Claiborne Johnston, Jordan J Elm, J Donald Easton, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neurology|September 4, 2009
Prospective validation of the ICH Score for 12-month functional outcomeJ Claude Hemphill, Mary Farrant, Terry A Neill
Neurocritical Care|December 27, 2005
Brain tissue oxygen monitoring in intracerebral hemorrhageJ Claude Hemphill, Diane Morabito, Mary Farrant, et al.
Neurocritical Care|September 22, 2005
External validation of the ICH scoreJennifer L Clarke, S Claiborne Johnston, Mary Farrant, et al.
Journal of the American Heart Association|March 8, 2021
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT TrialHooman Kamel, Mary Farrant, J Donald Easton, et al.
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
JAMA Neurology|August 20, 2019
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) TrialsYuesong Pan, Jordan J Elm, Hao Li, et al.
Circulation|June 27, 2019
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic StrokeS Claiborne Johnston, Jordan J Elm, J Donald Easton, et al.
Pageof 2